Response to comment on “Hypogonadotrophic hypogonadism due to a mutation in the luteinizing hormone β-subunit gene”

نویسنده

  • Sung-Hee Ihm
چکیده

Correspondence to Sung-Hee Ihm, M.D. Department of Internal Medicine, Hallym University Sacred Heart Hospital, 22 Gwanpyeong-ro 170beon-gil, Dongan-gu, Anyang 14068, Korea Tel: +82-31-380-3714 Fax: +82-31-386-2269 E-mail: [email protected] We thank Dr. Valdes-Socin and colleagues for the instructive comments on our case report [1] and for sharing their experience on induction of puberty and fertility in male patients with the very rare disease that is under discussion. We agree that the best initial therapeutic strategy for young males with luteinizing hormone (LH) deficiency is administration of human chorionic gonadotropin (hCG) or recombinant LH; these treatments improve spermatogenesis and maximize fertility potential [2]. In patients with hypogonadotrophic hypogonadism (HH), low-dose, intramuscular injections of testosterone have been the most commonly used regimen to induce puberty in young males who do not wish to be fertile in the near future. Gonadotropin treatment is physiological in nature but can be complex (requiring frequent injections) and thus is less commonly used than testosterone treatment. A recent, prospective multicenter study on adolescents with HH found that gonadotropins successfully induced both testicular growth and spermatogenesis, irrespective of prior full-dose testosterone replacement for up to 5.7 years [3]. However, some evidence suggests that prior long-term exposure to testosterone may negatively impact fertility potential of these patients. On the other hand, induction of puberty via gonadotropin injection may improve fertility potential of these patients. Although we used low-dose testosterone to induce pubertal changes in our present case (a convenient procedure complying with the wishes of the patient), we agree that the use of hCG or recombinant LH to induce puberty maximizes the testicular response and future potential fertility in patients with isolated LH deficiency.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Comment on “Hypogonadotrophic hypogonadism due to a mutation in the luteinizing hormone β-subunit gene”

Correspondence to Hernan Valdes-Socin, M.D. Department of Endocrinology, University Hospital Center of Liège, University of Liège, Liège 4000, Belgium Tel: +32-43667083 Fax: +32-43667261 E-mail: [email protected]. ac.be Song et al. [1], report a new case of a homozygous p.Leu72Arg mutation in exon 3 of the luteinizing hormone β (LHB) gene leading to hypogonadism in a 19-year-old male patie...

متن کامل

Frequency of the allelic variant (Trp8Arg/Ile15Thr) of the luteinizing hormone gene in a Brazilian cohort of healthy subjects and in patients with hypogonadotropic hypogonadism.

PURPOSE To evaluate the frequency of allelic variant Trp8Arg/Ile15Thr in the luteinizing hormone beta-subunit gene in a Brazilian population of healthy subjects and in patients with hypogonadotropic hypogonadism. SUBJECTS AND METHODS Two hundred and two adults (115 women) with normal sexual function and 48 patients (24 women) with hypogonadotropic hypogonadism underwent a molecular study of t...

متن کامل

P-128: Optimization of Human LH Gene Expression by Codon Usage Adaptation in CHO Cell Line

a:4:{s:10:"Background";s:897:"Human luteinizing hormone (hLH) belongs to glycoprotein hormones which is composed of two non-covalently linked subunit, α and β. The α-subunit is similar in all glycoprotein hormones, whereas the β-subunit is conferring the hormonal specificity. This hormone has important roles in the growth and maturity of sexual organs and secondary sexual characteristics and st...

متن کامل

Hypogonadism in a patient with a mutation in the luteinizing hormone beta-subunit gene.

A 30-year-old man who presented with delayed puberty and infertility was found to have hypogonadism associated with an absence of circulating luteinizing hormone. The patient had a homozygous missense mutation in the gene that encodes the beta subunit of luteinizing hormone (Gly36Asp), a mutation that disrupted a vital cystine knot motif and abrogated the heterodimerization and secretion of lut...

متن کامل

Recombinant follitropin alfa/lutropin alfa in fertility treatment

Recombinant human follicle stimulating hormone (rFSH) and luteinizing hormone (LH), also known as follitropin alpha and lutropin alpha, are manufactured by genetic engineering techniques which ensure high quality and batch to batch consistency. Follitropin alpha can be used for controlled ovarian hyperstimulation in assisted reproduction, ovulation induction for WHO group I and II anovulatory i...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 32  شماره 

صفحات  -

تاریخ انتشار 2017